主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMCR
#4436
Immunocore Holdings plc - American Depositary Shares
0.2
9
USD
-99.00%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-99.00%
每月变动
-98.97%
6个月变化
-99.26%
年变化
-99.14%
前一天收盘价
28.9
7
Open
0.2
9
最低价
0.2
9
High
0.2
9
交易量
29
市场
US Stock Market
医疗保健
IMCR
展开完整图表
完整图表
Financials
概览
声明
统计
每季度
年度
利润表
资产负债表
现金流
值
2020
2021
2022
2023
2024
2025
总资产
—
—
—
597 M
1.01 B
1.07 B
负债总额
—
—
—
228.16 M
648.79 M
686.24 M
权益总额
—
—
—
368.84 M
360.72 M
381.03 M
负债及股东权益总额
—
—
—
597 M
1.01 B
1.07 B
总债务
—
—
—
48.01 M
391.01 M
393.13 M
净债务
—
—
—
-394.62 M
-429.36 M
-471.03 M
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
新闻
FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy
FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer
Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?
AZN, Daiichi's Enhertu Gets Positive CHMP Opinion for Solid Tumors
AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity